On the basis of these studies, the goal of maximizing tumor cell destruction with conventional cancer therapy should also include specific cancer stem cell targets through pharmacological inhibition of self-renewal pathways and provoke even a greater apoptotic response by activating the target protein (blocking ΔNp73 to restore p53 function). The gene discussed is TP53; the disease is neoplasm.